Virtual Investor is a leading platform providing investors with direct access to innovative companies, management teams and thought leaders.
Featured Event:
5 for ’25
Featured Companies
Covered Companies
Covered Companies
Series
What This Means
Featuring: American Resources
March 7, 2025
Mark Jensen, CEO of American Resources Corporation and ReElement Technologies Corporation, discussed the Company’s production of rare earth elements and how American Resources is working to cost-effectively develop in-demand minerals for defense.
What This Means
Featuring: PalisadeBio
March 4, 2025
Dr. Joerg Heyer, Head of Translational Science and Medicine of Palisade Bio highlights preclinical data for lead product candidate, PALI-2108, for the treatment of Ulcerative Colitis (UC)
What This Means
Featuring: Sonnet BioTherapeutics
February 19, 2025
Sonnet BioTherapeutics Announces That Its Proprietary Antibody Drug Conjugate (ADC) Platform is Available for Drug Discovery Partnerships with Potential for Producing Multiple Pipeline Drug Candidates
What This Means
Featuring: Aim ImmunoTech
February 11, 2025
Tom Equels, CEO of AIM ImmunoTech and Professor Casper H.J. van Eijck, MD, PhD, Pancreato-biliary Surgeon at Erasmus MC, discuss the Phase 1b/2 clinical trial involving AIM’s Ampligen® (rintatolimod) and AstraZeneca’s anti-PD-L1 immune checkpoint inhibitor Imfinzi® (durvalumab) in the treatment of late-stage pancreatic cancer (“DURIPANC”)
Past Events
New to Virtual Investor
Closing Bell
Live What This Means
Closing Bell Series
New to the Street
Live What This Means
Past Events
Join Us
Sign up for email alerts to stay up-to-date on the latest Virtual Investor events
By submitting this form, you are consenting to receive marketing emails from: Virtual Investor. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact